Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles

Lerche S, Wurster I, Roeben B, Zimmermann M, Riebenbauer B, Deuschle C, Hauser AK, Schulte C, Berg D, Maetzler W, Waniek K, Lachmann I, Liepelt-Scarfone I, Gasser T, Brockmann K.

Mov Disord. 2020 Mar;35(3):495-499. doi: 10.1002/mds.27884. Epub 2019 Oct 30.

A turn for the worse: Turning performance in Parkinson's disease and Essential tremor.

Baudendistel ST, Schmitt AC, Rodriguez AV, McFarland NR, Hass CJ.

Clin Biomech (Bristol, Avon). 2019 Oct 22;70:245-248. doi: 10.1016/j.clinbiomech.2019.09.008. [Epub ahead of print]

A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease

Aflaki E, Stubblefield BK, McGlinchey RP, McMahon B, Ory DS, Sidransky E.

Neurobiol Dis. 2020 Feb;134:104647. doi: 10.1016/j.nbd.2019.104647. Epub 2019 Nov 10.

Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain

Li Y, Chen N, Wu C, Lu Y, Gao G, Duan C, Yang H, Lu L.

Brain Behav Immun. 2020 Jan;83:214-225. doi: 10.1016/j.bbi.2019.10.015. Epub 2019 Oct 25.

Does a Sway-Based Mobile Application Predict Future Falls in People With Parkinson Disease?

Fiems CL, Miller SA, Buchanan N, Knowles E, Larson E, Snow R, Moore ES.

Arch Phys Med Rehabil. 2020 Mar;101(3):472-478. doi: 10.1016/j.apmr.2019.09.013. Epub 2019 Oct 24.

Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study

Blaise AS, Baille G, Carrière N, Devos D, Dujardin K, Grolez G, Kreisler A, Kyheng M, Moreau C, Mutez E, Seguy D, Defebvre L.

Rev Neurol (Paris). 2020 May;176(4):268-276. doi: 10.1016/j.neurol.2019.07.024. Epub 2019 Oct 23.

Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia

Mantas I, Yang Y, Mannoury-la-Cour C, Millan MJ, Zhang X, Svenningsson P.

Neuropharmacology. 2020 Jan 1;162:107829. doi: 10.1016/j.neuropharm.2019.107829. Epub 2019 Oct 24.

Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study.

Picca A, Calvani R, Landi G, Marini F, Biancolillo A, Gervasoni J, Persichilli S, Primiano A, Urbani A, Bossola M, Bentivoglio AR, Cesari M, Landi F, Bernabei R, Marzetti E, Monaco MRL.

Exp Gerontol. 2019 Oct 27:110766. doi: 10.1016/j.exger.2019.110766. [Epub ahead of print]

Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease.

Stanojlovic M, Pallais JP, Lee MK, Kotz CM.

Mol Brain. 2019 Oct 30;12(1):87. doi: 10.1186/s13041-019-0514-8.

Effect of simplified Tai Chi exercise on relieving symptoms of patients with mild to moderate Parkinson's disease

Zhu M, Zhang Y, Pan J, Fu C, Wang Y.

J Sports Med Phys Fitness. 2020 Feb;60(2):282-288. doi: 10.23736/S0022-4707.19.10104-1. Epub 2019 Oct 25.

Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?

Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D, Reich SG, Shprecher D, Hall D, Marras C, Kluger B, Olfati N, Jankovic J.

Parkinsonism Relat Disord. 2019 Oct 14;69:34-39. doi: 10.1016/j.parkreldis.2019.10.012. [Epub ahead of print]

Stimulation challenge test after STN DBS improves satisfaction in Parkinson's disease patients.

Geraedts VJ, van Hilten JJ, Marinus J, Mosch A, Naarding KJ, Hoffmann CFE, van der Gaag NA, Contarino MF.

Parkinsonism Relat Disord. 2019 Oct 15;69:30-33. doi: 10.1016/j.parkreldis.2019.10.014. [Epub ahead of print]

Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.

Nigro S, Barbagallo G, Bianco MG, Morelli M, Arabia G, Quattrone A, Gasparini S, Cascini GL, Quattrone A.

Parkinsonism Relat Disord. 2019 Oct 22;69:23-29. doi: 10.1016/j.parkreldis.2019.10.020. [Epub ahead of print]

Helping People With Parkinson Disease Build Exercise Self-Efficacy

Stevens A, Stanton R, Rebar AL.

Phys Ther. 2020 Feb 7;100(2):205-208. doi: 10.1093/ptj/pzz160.

The structural connectivity of discrete networks underlies impulsivity and gambling in Parkinson's disease.

Mosley PE, Paliwal S, Robinson K, Coyne T, Silburn P, Tittgemeyer M, Stephan KE, Breakspear M, Perry A.

Brain. 2019 Oct 27. pii: awz327. doi: 10.1093/brain/awz327. [Epub ahead of print]